Frank Berthold

27.0k total citations · 4 hit papers
320 papers, 16.4k citations indexed

About

Frank Berthold is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Frank Berthold has authored 320 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Neurology, 113 papers in Molecular Biology and 84 papers in Cancer Research. Recurrent topics in Frank Berthold's work include Neuroblastoma Research and Treatments (221 papers), Cancer, Hypoxia, and Metabolism (79 papers) and Cancer therapeutics and mechanisms (62 papers). Frank Berthold is often cited by papers focused on Neuroblastoma Research and Treatments (221 papers), Cancer, Hypoxia, and Metabolism (79 papers) and Cancer therapeutics and mechanisms (62 papers). Frank Berthold collaborates with scholars based in Germany, United States and United Kingdom. Frank Berthold's co-authors include Barbara Hero, Thorsten Simon, Manfred Schwab, Frank Westermann, M Favrot, Victoria Castel, Bruno De Bernardi, Audrey E. Evans, G M Brodeur and Jon Pritchard and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Frank Berthold

317 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

2001 1.9k citations Frank Westermann, Frank Berthold et al. profile →
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1993 1.7k citations Frank Berthold, Victoria Castel et al. Journal of Clinical Oncology profile →
Advances in Risk Classification and Treatment Strategies for Neuroblastoma

2015 611 citations Katherine K. Matthay, Wendy B. London et al. Journal of Clinical Oncology profile →
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

1988 457 citations Frank Berthold et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Frank Berthold

Since Specialization

Citations

This map shows the geographic impact of Frank Berthold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Berthold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Berthold more than expected).

Fields of papers citing papers by Frank Berthold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Berthold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Berthold. The network helps show where Frank Berthold may publish in the future.

Co-authorship network of co-authors of Frank Berthold

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Berthold. A scholar is included among the top collaborators of Frank Berthold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Berthold. Frank Berthold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma 2023 ·Pediatric Blood & Cancer ·(unknown), B. Krug, (unknown), Jörg Fuchs, Steven W. Warmann, Jochen Hubertus, Friederike Körber, Frank Berthold, Thorsten Simon, Barbara Hero	2
2	Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Nicole Bechmann, (unknown), Georgiana Constantinescu, Anthony Stell, Angela Ernst, Frank Berthold, Frank Westermann, Jingjing Jiang, (unknown), Elisabeth Nowak, Stephanie Zopp, Karel Pacák, Mirko Peitzsch, Andreas Schedl, Martín Reincke, Felix Beuschlein, Stefan R. Bornstein, Martin Faßnacht, Graeme Eisenhofer	7
3	Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification 2021 ·Cancers ·Frank Berthold, Angela Ernst, Sandra Ackermann, Christoph Bartenhagen, Holger Christiansen, Barbara Hero, Carolina Rosswog, Dietrich von Schweinitz, Thomas Klingebiel, Irene Schmid, Thorsten Simon, Matthias Fischer	2
4	Hypercalcemia is a frequent side effect of 13‐cis‐retinoic acid treatment in patients with high‐risk neuroblastoma 2021 ·Pediatric Blood & Cancer ·(unknown), (unknown), Frank Berthold, Thorsten Simon, Barbara Hero	4
5	Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial 2021 ·JNCI Cancer Spectrum ·Frank Berthold, Claudia Spix, R. Erttmann, Barbara Hero, J. Michaelis, J. Treuner, Angela Ernst, Freimut H. Schilling	6
6	Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification 2021 ·Pediatric Blood & Cancer ·Frank Berthold, Carolina Rosswog, Holger Christiansen, Michael C. Frühwald, (unknown), Thomas Klingebiel, Birgit Fröhlich, Freimut H. Schilling, Irene Schmid, Thorsten Simon, Barbara Hero, Matthias Fischer, Angela Ernst	4
7	The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project 2020 ·Pediatric Blood & Cancer ·V. V. Moroz, David Machin, Barbara Hero, Ruth Ladenstein, Frank Berthold, (unknown), (unknown), Andrew D.J. Pearson, Susan L. Cohn, Wendy B. London	32
8	Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine 2019 ·Pediatric Blood & Cancer ·Mirko Peitzsch, Elizabeth R. Butch, (unknown), Anastasios Mangelis, Wayne L. Furman, Victor M. Santana, Barbara Hero, Frank Berthold, Barry L. Shulkin, Angela Huebner, Graeme Eisenhofer	16
9	Role of Surgery in the Treatment of Patients With Stage 4 Neuroblastoma Age 18 Months or Older at Diagnosis 2013 ·Journal of Clinical Oncology ·Thorsten Simon, Beate Häberle, Barbara Hero, Dietrich von Schweinitz, Frank Berthold	84
10	Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project 2011 ·Journal of Clinical Oncology ·Wendy B. London, Victoria Castel, Tom Monclair, Peter F. Ambros, Andrew D.J. Pearson, Susan L. Cohn, Frank Berthold, Akira Nakagawara, Ruth Ladenstein, Tomoko Iehara, Katherine K. Matthay	229
11	High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma 2011 ·Clinical Cancer Research ·Johannes H. Schulte, Hagen S. Bachmann, (unknown), Katleen De Preter, André Oberthür, Sandra Ackermann, Yvonne Kahlert, Kristian W. Pajtler, Jessica Theißen, Frank Westermann, Jo Vandesompele, Frank Speleman, Frank Berthold, Angelika Eggert, Benedikt Brors, Barbara Hero, Alexander Schramm, Matthias Fischer	72
12	SURVIVAL AFTER RECURRENCE OF METASTATIC RHAFIDOMYOSARCOMA - AN UNPROBABLE, BUT NOT IMPOSSIBLE EVENT IN THE EXPERIENCE OF THE COOPERATIVE WEICHTEILSARKOM STUDIENGRUPPE (CWS) 2010 ·Pediatric Blood & Cancer ·Tobias M. Dantonello, Ivo Leuschner, (unknown), Andreas Schuck, Gustaf Ljungman, Niklas Pal, Frank Berthold, Stefan Bielack, J. Treuner, Thomas Klingebiel, Ewa Kościelniak	1
13	Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma 2009 ·BMC Molecular Biology ·Harald Voth, André Oberthuer, Thorsten Simon, Yvonne Kahlert, Frank Berthold, Matthias Fischer	36
14	Long-term investigation of glass electrodes at higher temperatures 2009 ·Chemia Analityczna ·(unknown), Frank Berthold, (unknown), U. Guth	0
15	Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR 2008 ·Clinical Cancer Research ·André Oberthuer, Lars Kaderali, Yvonne Kahlert, Barbara Hero, Frank Westermann, Frank Berthold, Benedikt Brors, Roland Eils, Matthias Fischer	19
16	MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S 2008 ·Molecular Oncology ·Jean Bénard, Gilda Raguénez, Audrey Kauffmann, Alexander Valent, Hugues Ripoche, V. Joulin, Bastien Job, Gisèle Danglot, (unknown), Thomas Robert, Marie‐José Terrier‐Lacombe, Agnès Chassevent, Serge Koscielny, Matthias Fischer, Frank Berthold, Marc Lipinski, Thomas Tursz, Philippe Dessen, Vladimir Lazar, Dominique Valteau‐Couanet	50
17	Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome 2006 ·Clinical Cancer Research ·Matthias Fischer, André Oberthuer, Benedikt Brors, Yvonne Kahlert, (unknown), Harald Voth, Patrick Warnat, Karen Ernestus, Barbara Hero, Frank Berthold	46
18	Analysis of HIC‐1 methylation and transcription in human ependymomas 2004 ·International Journal of Cancer ·Anke Waha, Arend Koch, Wolfgang Hartmann, (unknown), Johannes Schramm, Niels Sörensen, Frank Berthold, Otmar D. Wiestler, Torsten Pietsch, Andreas Waha	44
19	Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma 2003 ·American Journal Of Pathology ·Matthias Krams, Barbara Hero, Frank Berthold, Reza Parwaresch, D. Harms, Pierre Rudolph	38
20	Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene 2002 ·Neuropathology and Applied Neurobiology ·J. Kraus, (unknown), N. Sörensen, Frank Berthold, Uwe Schlegel, J.-C. Tonn, O. D. Wiestler, Torsten Pietsch	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact